Colchicine Dosing for Elderly Patients with Gout

Standard Dosing Approach

The American College of Rheumatology recommends a prophylactic regimen of colchicine to be continued for at least the first 6 months when initiating urate-lowering therapy in patients with gout, with a dose of 0.6 mg once or twice daily, with a maximum of 1.2 mg/day 1, 2
For acute gout flare treatment, administer 1.2 mg at the first sign of flare, followed by 0.6 mg one hour later, with treatment to be initiated within 36 hours of symptom onset for maximum effectiveness 1

The European League Against Rheumatism suggests that elderly patients with severe renal impairment (CrCl <30 mL/min) should start with a prophylaxis dose of 0.3 mg daily, with any dose increase requiring careful monitoring, and acute treatment should be a single dose of 0.6 mg only, with repeat no more than once every 2 weeks 3
Dialysis patients should receive 0.3 mg twice weekly for prophylaxis, with close monitoring, and a single 0.6 mg dose for acute treatment, with repeat no more than once every 2 weeks 3

The American College of Rheumatology recommends monitoring closely for signs of toxicity, particularly creatinine phosphokinase (CPK) levels, especially in those with renal impairment, neuromuscular toxicity symptoms, and gastrointestinal symptoms in elderly patients on colchicine 3, 2

The American Geriatrics Society advises against assuming elderly patients need automatic dose reduction based on age alone, and against using high-dose regimens (>1.8 mg in first hour), which provide no additional benefit but substantially increase adverse events 1
The European League Against Rheumatism recommends against combining colchicine with strong CYP3A4 inhibitors in patients with any degree of renal or hepatic impairment, and against continuing prophylaxis beyond 6 months without specific indication 2